Loading...
NPI 1720029960 · Murray, UT · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ihc Health Services, Inc. is a clinical medical laboratory provider located in Murray, Utah. This profile covers 280 Medicare and 219 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Ihc Health Services, Inc. |
| Address | 5252 South, Intermountain Drive |
| City | Murray |
| State | UT |
| ZIP | 84107 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 9, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $17.9M |
| Medicare | $2.7M |
IHC HEALTH SERVICES, INC. is a Clinical Medical Laboratory in Murray, UT with an NPI enumerated 2006-06-09 (~20 years ago). The entity reports $2.7M in total Medicare revenue and $17.9M in total Medicaid revenue, indicating an established lab operation with nearly two decades of enrollment and substantial billing activity across both programs.
The provider’s payer mix is heavily Medicaid-weighted: total Medicaid revenue ($17.9M) substantially exceeds total Medicare revenue ($2.7M), making Medicaid the dominant source of billed revenue for this provider. This scale difference suggests the lab’s business footprint and client base are concentrated in the Medicaid population and state-level contracting.
Medicare revenue shows concentration in a small set of procedures: the top 3 Medicare codes account for 34.2% of Medicare revenue, led by 36415, 80053, and 80061. These codes are largely consumptive of high-volume specimen collection (36415) and common chemistry panels (80053, 80061), indicating routine outpatient specimen processing and high-throughput panel testing are core to the Medicare-facing service line.
Medicaid revenue is even more concentrated: the top 3 Medicaid codes account for 57.7% of Medicaid revenue, driven by 87635 ($5.4M), U0003 ($2.1M), and 36415 ($1.3M). The dominance of 87635 and U0003 (SARS-CoV-2 NAATs) plus phlebotomy implies a large operational emphasis on high-volume COVID PCR testing combined with basic specimen collection and panel work for the state program.
On competitive standing, the provider is a statistically dominant performer for several codes. Nationally for Medicare, 36415 ranks #84 of 86,467 providers (100th percentile) and is labeled an "extreme outlier," showing exceptionally high specimen-collection volume compared with peers, while many other Medicare panel and analyte codes rank in the high percentiles but are described as typical, unremarkable volumes.
At the state level the provider is a clear market leader for many Medicaid codes: 87635 ranks #1 of 74 in-state (100th percentile; extreme outlier), 80050 ranks #1 of 51 (100th percentile; extreme outlier), and multiple culture and panel codes (87086, 80061, 87491, 87070, 87186, 87081, 87077) also rank #1 in-state and are described as extreme outliers. These in-state rankings indicate IHC HEALTH SERVICES operates at a scale for certain services that far exceeds other Utah-based labs.
The code mix points to a full-service high-throughput laboratory model: large volumes of molecular infectious testing (87635, U0003), routine chemistry and OB panels (80050, 80053, 80061, 80081), vitamin/metabolic markers (82306), microbiology and culture work (87070, 87081, 87086, 87077, 87186), and extensive phlebotomy throughput (). This combination supports an operational profile focused on central processing for community screening, infectious disease surveillance, prenatal/OB screening, and routine outpatient diagnostics.
Multiple specific codes are flagged as statistical outliers or notably above typical volumes across payers and geographies and therefore warrant attention when assessing competitive positioning and contract exposure. Examples include the extreme outlier status of 87635 and the extreme national outlier status of 36415, plus numerous #1 in-state rankings for panels and cultures; these concentration and outlier signals are important context for payer negotiations, network adequacy reviews, and capacity assessments.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
280 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 35,640 | $10 | $285.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 23,420 | $10 | $234.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 15,360 | $10 | $199.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 11,620 | $20 | $185.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 18,430 | $10 | $147.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 4,770 | $30 | $138.3K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 9,580 | $10 | $95.8K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 2,300 | $40 | $92K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 5,900 | $20 | $88.4K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 8,150 | $10 | $65.2K |
Showing 1–10 of 280
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 280 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
280 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 4 | 10 | 480 | $30 | $226.9K |
| U0003 | 2 | 10 | 390 | $70 | $46.3K |
| 87640 | 2 | 10 | 1,010 | $30 | $34.8K |
| G0480 | 5 | 10 | 70 | $110 | $30.5K |
| 87491 | 2 | 10 | 890 | $30 | $30.5K |
| 87591 | 2 | 10 | 890 | $30 | $30.3K |
| 88305 | 154 | 150 | 360 | $40 | $23.4K |
| 80307 | 6 | 20 | 100 | $60 | $21.7K |
| U0005 | 3 | 10 | 560 | $20 | $20.7K |
| G0482 | 2 | 20 | 70 | $180 | $20.2K |
Showing 1–10 of 280
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
219 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 110,300 | $50 | $5.4M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 28,070 | $70 | $2.1M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 98,240 | $10 | $1.3M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 16,960 | $50 | $780K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 26,660 | $30 | $666.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 57,370 | $10 | $516.3K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 19,600 | $30 | $490.1K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 10,960 | $40 | $449.3K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 6,220 | $70 | $423.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 36,050 | $10 | $396.6K |
Showing 1–10 of 219
How this provider's Medicaid billing volume and revenue compare to other Utah providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Utah median
219 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 3 | 10 | 550 | $130 | $2.8M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 17 | 70 | 1,610 | $30 | $367.9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 3 | 20 | 270 | $40 | $334.7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 38 | 40 | 770 | $90 | $231.9K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 2 | 10 | 1,120 | $170 | $197.3K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2 | 10 | 480 | $110 | $189.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 5 | 120 | 1,100 | $30 | $186.6K |
| 0241U | N/A | 7 | 70 | 770 | $130 | $162.4K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 2 | 240 | 220 | $50 | $145.2K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 1 | 70 | 340 | $50 | $117.7K |
Showing 1–10 of 219
Other providers in the same ZIP code as Ihc Health Services, Inc., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.